Needham & Company LLC Reaffirms “Buy” Rating for Bicycle Therapeutics (NASDAQ:BCYC)
Needham & Company LLC reaffirmed their buy rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a research note released on Wednesday morning,...
Blueprint Medicines (NASDAQ:BPMC) Earns Market Outperform Rating from JMP Securities
JMP Securities reiterated their market outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a research report sent to investors on Wednesday...
Cognyte Software (NASDAQ:CGNT) Raised to Strong-Buy at StockNews.com
StockNews.com upgraded shares of Cognyte Software (NASDAQ:CGNT – Free Report) from a buy rating to a strong-buy rating in a report published on Wednesday morning....
Churchill Downs (NASDAQ:CHDN) Earns Market Outperform Rating from JMP Securities
JMP Securities reiterated their market outperform rating on shares of Churchill Downs (NASDAQ:CHDN – Free Report) in a research report sent to investors on Wednesday...
Keefe, Bruyette & Woods Boosts Cincinnati Financial (NASDAQ:CINF) Price Target to $143.00
Cincinnati Financial (NASDAQ:CINF – Free Report) had its target price lifted by Keefe, Bruyette & Woods from $136.00 to $143.00 in a research note published...
CleanSpark (NASDAQ:CLSK) Price Target Raised to $15.00
CleanSpark (NASDAQ:CLSK – Free Report) had its price objective increased by JPMorgan Chase & Co. from $14.00 to $15.00 in a report released on Wednesday,...
